The metabolism of phenolic opiates by rat intestine
- PMID: 414464
- DOI: 10.3109/00498257709038688
The metabolism of phenolic opiates by rat intestine
Abstract
1. A range of phenolic opiate agonists and antagonists undergo conjugation during passage across the rat intestine. 2. The efficiency of conjugation, mediated by gut UDP-glucoronyltransferase, is a function of the lipophilicity of the substrate. 3. Conjugation of lipophilic substrates such as buprenorphine and etorphine in rat intestinal mucosa is such that the gut wall must be regarded as the primary site of metabolism of these compounds after oral administration. 4. N-Dealkylation of the N-cyclopropylmethyl opiate, buprenorphine, has been demonstrated in rat gut sacs though dealkylation of N-methyl substrates was not detected.
Similar articles
-
Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds.Drug Metab Dispos. 1997 Feb;25(2):251-5. Drug Metab Dispos. 1997. PMID: 9029056
-
The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1.Arch Biochem Biophys. 1996 Aug 1;332(1):92-100. doi: 10.1006/abbi.1996.0320. Arch Biochem Biophys. 1996. PMID: 8806713
-
Transport mechanisms for narcotics and narcotic antagonists in alimentary epithelia.J Pharmacol Exp Ther. 1981 May;217(2):285-91. J Pharmacol Exp Ther. 1981. PMID: 7229972
-
Cytochrome P450-mediated metabolism in the human gut wall.J Pharm Pharmacol. 2009 May;61(5):541-58. doi: 10.1211/jpp/61.05.0002. J Pharm Pharmacol. 2009. PMID: 19405992 Review.
-
Clinical pharmacokinetics of narcotic agonist-antagonist drugs.Clin Pharmacokinet. 1983 Jul-Aug;8(4):332-43. doi: 10.2165/00003088-198308040-00004. Clin Pharmacokinet. 1983. PMID: 6352139 Review. No abstract available.
Cited by
-
Transdermal buprenorphine - a critical appraisal of its role in pain management.J Pain Res. 2009 Sep 15;2:117-34. doi: 10.2147/jpr.s6503. J Pain Res. 2009. PMID: 21197300 Free PMC article.
-
Drug metabolism by the gastrointestinal mucosa.Clin Pharmacokinet. 1981 Jul-Aug;6(4):259-74. doi: 10.2165/00003088-198106040-00002. Clin Pharmacokinet. 1981. PMID: 6113909
-
Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.Drugs. 1979 Feb;17(2):81-110. doi: 10.2165/00003495-197917020-00001. Drugs. 1979. PMID: 378645 Review.
-
The systemic availability of meptazinol in man after oral and rectal doses.Eur J Clin Pharmacol. 1989;36(3):279-82. doi: 10.1007/BF00558160. Eur J Clin Pharmacol. 1989. PMID: 2744068 Clinical Trial.
-
Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction.CNS Drug Rev. 2002 Winter;8(4):377-90. doi: 10.1111/j.1527-3458.2002.tb00235.x. CNS Drug Rev. 2002. PMID: 12481193 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources